Back to Results
First PageMeta Content
Malaria / RTS / S / Malaria vaccine / GlaxoSmithKline / TBVI / Program for Appropriate Technology in Health / Medicine / Vaccines / Health


Document Date: 2010-05-03 13:14:19

Open Document

File Size: 33,31 KB

Share Result on Facebook

Company

GlaxoSmithKline / Glaxosmithkline plc / MVI / /

Continent

Africa / /

Country

Belgium / United States / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

Walter Reed Army Institute of Research / GSK Biologicals’ headquarters / /

IndustryTerm

appropriate health technologies / /

MedicalCondition

next-generation malaria / malaria / neglected diseases / /

Organization

Walter Reed Army Institute of Research / Melinda Gates Foundation / About PATH PATH / Council on Foreign Relations / Clinical Trials Partnership Committee / /

Person

Andrew Witty / Christian Loucq / Christopher J. Elias / Preeti Singh / /

/

Position

CEO / director / president and CEO / /

Product

PATH / /

ProvinceOrState

Washington / /

Technology

appropriate health technologies / /

URL

www.path.org / www.malariavaccine.org / /

SocialTag